SEC filing · 8-K

Stoke Therapeutics, Inc.: Executive or director change

Stoke Therapeutics announced the resignation of director Edward M. Kaye and the appointment of Alexander (Bo) Cumbo to its Board of Directors.

Filed September 25, 2026

Neutral news

What happened

Dr. Edward M. Kaye resigned as a Class III director and as a member of the Research and Development Committee, effective September 23, 2026.

The full interpretation is in the app

Why it matters, the key numbers from the document and what to watch next: the full interpretation of every report is part of Pro.

Read the full interpretation

Read the original

Filing document on SEC.gov All documents of this filing

Back to Stoke Therapeutics, Inc.

Summary generated automatically from the filing text and checked against it: every number above is printed in the document. It describes the filing and is not investment advice. Read the original before relying on it.